• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高基线表达的白细胞介素-6 和白细胞介素-10 减少了先前感染过 SARS-CoV-2 的个体在接种 BNT162b2 疫苗时的 CCR7+B 细胞。

High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination.

机构信息

Laboratorio de Inmunología, Unidad de Morfología y Función, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Estado de México, Mexico.

Secretaría de Salud de Veracruz, Servicios de Salud de Veracruz, SESVER, Xalapa Veracruz, Mexico.

出版信息

Front Immunol. 2022 Aug 16;13:946770. doi: 10.3389/fimmu.2022.946770. eCollection 2022.

DOI:10.3389/fimmu.2022.946770
PMID:36052060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425053/
Abstract

The current pandemic generated by SARS-CoV-2 has led to mass vaccination with different biologics that have shown wide variations among human populations according to the origin and formulation of the vaccine. Studies evaluating the response in individuals with a natural infection before vaccination have been limited to antibody titer analysis and evaluating a few humoral and cellular response markers, showing a more rapid and intense humoral response than individuals without prior infection. However, the basis of these differences has not been explored in depth. In the present work, we analyzed a group of pro and anti-inflammatory cytokines, antibody titers, and cell populations in peripheral blood of individuals with previous SARS-CoV-2 infection using BNT162b2 biologic. Our results suggest that higher antibody concentration in individuals with an earlier disease could be generated by higher production of plasma cells to the detriment of the presence of memory B cells in the bloodstream, which could be related to the high baseline expression of cytokines (IL-6 and IL-10) before vaccination.

摘要

当前由 SARS-CoV-2 引起的大流行导致了针对不同生物制剂的大规模疫苗接种,根据疫苗的来源和配方,这些生物制剂在人类群体中显示出广泛的差异。评估个体在接种疫苗前自然感染后的反应的研究仅限于抗体滴度分析和评估少数体液和细胞反应标志物,显示出比没有先前感染的个体更快和更强烈的体液反应。然而,这些差异的基础尚未深入探讨。在本工作中,我们使用 BNT162b2 生物制剂分析了一组先前感染过 SARS-CoV-2 的个体的外周血中的促炎和抗炎细胞因子、抗体滴度和细胞群体。我们的结果表明,早期疾病患者体内更高的抗体浓度可能是由于浆细胞产生增加而导致的,这对血液中记忆 B 细胞的存在不利,这可能与接种前细胞因子(IL-6 和 IL-10)的高基线表达有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/dad5a4990def/fimmu-13-946770-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/4aa56779dced/fimmu-13-946770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/ad1f4f5067a7/fimmu-13-946770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/87421bd4defb/fimmu-13-946770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/dad5a4990def/fimmu-13-946770-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/4aa56779dced/fimmu-13-946770-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/ad1f4f5067a7/fimmu-13-946770-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/87421bd4defb/fimmu-13-946770-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2aa/9425053/dad5a4990def/fimmu-13-946770-g004.jpg

相似文献

1
High baseline expression of IL-6 and IL-10 decreased CCR7 B cells in individuals with previous SARS-CoV-2 infection during BNT162b2 vaccination.高基线表达的白细胞介素-6 和白细胞介素-10 减少了先前感染过 SARS-CoV-2 的个体在接种 BNT162b2 疫苗时的 CCR7+B 细胞。
Front Immunol. 2022 Aug 16;13:946770. doi: 10.3389/fimmu.2022.946770. eCollection 2022.
2
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis.影响 SARS-CoV-2 感染和接种疫苗诱导的类风湿关节炎免疫反应的因素。
Front Immunol. 2022 Oct 12;13:960001. doi: 10.3389/fimmu.2022.960001. eCollection 2022.
3
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.接种 BNT162b2 mRNA 疫苗的血液恶性肿瘤移植患者体内 SARS-CoV-2 抗体和固有细胞因子减少。
Front Immunol. 2022 May 25;13:899972. doi: 10.3389/fimmu.2022.899972. eCollection 2022.
4
Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.严重肥胖人群对 SARS-CoV-2 疫苗的抗体反应。
Obes Surg. 2022 Sep;32(9):2987-2993. doi: 10.1007/s11695-022-06181-y. Epub 2022 Jul 8.
5
Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile.智利使用科兴(Sinovac)的克尔来福(CoronaVac)和辉瑞/生物科技(Pfizer/BioNTech)的 BNT162b2 疫苗进行异源接种对 2019 冠状病毒病的体液免疫。
Front Public Health. 2023 Aug 24;11:1229045. doi: 10.3389/fpubh.2023.1229045. eCollection 2023.
6
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine.接种 BNT162b2 疫苗十个月后,对大量医护人员的抗体滴度动力学和 SARS-CoV-2 感染进行评估。
J Immunol Methods. 2022 Jul;506:113293. doi: 10.1016/j.jim.2022.113293. Epub 2022 Jun 2.
7
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
8
SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.第三剂科兴或辉瑞疫苗加强针后医护人员针对 SARS-CoV-2 的抗体反应。
J Med Virol. 2022 Aug;94(8):3768-3775. doi: 10.1002/jmv.27794. Epub 2022 Apr 23.
9
Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study.母体感染新型冠状病毒 2 型(SARS-CoV-2)或接种 SARS-CoV-2 疫苗会引发胎儿的炎症反应吗?一项前瞻性队列研究。
Gynecol Obstet Invest. 2022;87(3-4):219-225. doi: 10.1159/000525625. Epub 2022 Jun 21.
10
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff.在接受两剂 BNT162b2 mRNA SARS-CoV-2 疫苗接种后,年龄较小、女性、存在全身不良反应与高疫苗接种后抗体滴度相关:一项对 646 名日本医护人员和大学教职工的观察性研究。
Vaccine. 2022 Feb 11;40(7):1019-1025. doi: 10.1016/j.vaccine.2022.01.002. Epub 2022 Jan 7.

引用本文的文献

1
Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.评估 BNT162b2 疫苗接种医护人员中的 SARS-CoV-2 干扰素γ释放试验。
PLoS One. 2024 May 10;19(5):e0303244. doi: 10.1371/journal.pone.0303244. eCollection 2024.

本文引用的文献

1
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals.全面流式细胞术分析 COVID-19 康复个体的免疫系统。
Front Immunol. 2022 Jan 6;12:793142. doi: 10.3389/fimmu.2021.793142. eCollection 2021.
2
A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels.深入探究 COVID-19 严重程度与血液细胞因子水平的动态变化
Front Immunol. 2021 Nov 9;12:771609. doi: 10.3389/fimmu.2021.771609. eCollection 2021.
3
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.
T 细胞和抗体对先前感染和 SARS-CoV-2 阴性的英国医护人员第一剂 BNT162b2 疫苗的反应:一项多中心前瞻性队列研究。
Lancet Microbe. 2022 Jan;3(1):e21-e31. doi: 10.1016/S2666-5247(21)00275-5. Epub 2021 Nov 9.
4
Antibody Response after BNT162b2 Vaccination in Healthcare Workers Previously Exposed and Not Exposed to SARS-CoV-2.曾接触和未接触过SARS-CoV-2的医护人员接种BNT162b2疫苗后的抗体反应。
J Clin Med. 2021 Sep 17;10(18):4204. doi: 10.3390/jcm10184204.
5
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.接种BNT162b2和mRNA-1273后新型冠状病毒2型抗体反应的比较
JAMA. 2021 Oct 19;326(15):1533-1535. doi: 10.1001/jama.2021.15125.
6
Time of day influences immune response to an inactivated vaccine against SARS-CoV-2.一天中的不同时间会影响对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)灭活疫苗的免疫反应。
Cell Res. 2021 Nov;31(11):1215-1217. doi: 10.1038/s41422-021-00541-6. Epub 2021 Aug 2.
7
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.英国普通人群中 45965 名成年人对 SARS-CoV-2 疫苗的抗体反应。
Nat Microbiol. 2021 Sep;6(9):1140-1149. doi: 10.1038/s41564-021-00947-3. Epub 2021 Jul 21.
8
Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis.急性感染和恢复期针对 SARS-CoV-2 的中和抗体流行率:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009551. doi: 10.1371/journal.pntd.0009551. eCollection 2021 Jul.
9
Antibody and B cell responses to SARS-CoV-2 infection and vaccination.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疫苗接种的抗体及B细胞反应。
Cell Host Microbe. 2021 Jul 14;29(7):1063-1075. doi: 10.1016/j.chom.2021.06.009. Epub 2021 Jun 17.
10
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.mRNA 疫苗接种后 SARS-CoV-2 初免者和康复者的抗体和记忆 B 细胞反应存在差异。
Sci Immunol. 2021 Apr 15;6(58). doi: 10.1126/sciimmunol.abi6950.